Perspective Therapeutics Inc (CATX)
9.93
-0.74
(-6.94%)
USD |
NYAM |
Nov 13, 16:00
9.93
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics Research and Development Expense (Quarterly): 9.275M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.275M |
| March 31, 2024 | 7.452M |
| December 31, 2023 | 6.08M |
| September 30, 2023 | 5.721M |
| June 30, 2023 | 5.37M |
| March 31, 2023 | 3.309M |
| September 30, 2022 | 0.708M |
| June 30, 2022 | 0.796M |
| March 31, 2022 | 0.549M |
| December 31, 2021 | 0.535M |
| September 30, 2021 | 0.702M |
| June 30, 2021 | 0.468M |
| March 31, 2021 | 0.362M |
| December 31, 2020 | 0.285M |
| September 30, 2020 | 0.312M |
| June 30, 2020 | 0.322M |
| March 31, 2020 | 0.294M |
| December 31, 2019 | 0.277M |
| September 30, 2019 | 0.233M |
| June 30, 2019 | 0.341M |
| March 31, 2019 | 0.299M |
| December 31, 2018 | 0.414M |
| September 30, 2018 | 0.42M |
| June 30, 2018 | 0.572M |
| March 31, 2018 | 0.473M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.34M |
| September 30, 2017 | 0.362M |
| June 30, 2017 | 0.316M |
| March 31, 2017 | 0.327M |
| December 31, 2016 | 0.15M |
| September 30, 2016 | 0.172M |
| June 30, 2016 | 0.143M |
| March 31, 2016 | 0.183M |
| December 31, 2015 | 0.058M |
| September 30, 2015 | 0.144M |
| June 30, 2015 | 0.1564M |
| March 31, 2015 | 0.1414M |
| December 31, 2014 | 0.1406M |
| September 30, 2014 | 0.1766M |
| June 30, 2014 | 0.1982M |
| March 31, 2014 | 0.1536M |
| December 31, 2013 | 0.17M |
| September 30, 2013 | 0.147M |
| June 30, 2013 | 0.1813M |
| March 31, 2013 | 0.1551M |
| December 31, 2012 | 0.1492M |
| September 30, 2012 | 0.1415M |
| June 30, 2012 | 0.2074M |
| March 31, 2012 | 0.1322M |
| December 31, 2011 | 0.1897M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.277M
Minimum
Dec 2019
9.275M
Maximum
Jun 2024
2.379M
Average
0.6255M
Median
Research and Development Expense (Quarterly) Benchmarks
| Spectral AI Inc | -- |
| Retractable Technologies Inc | 0.1991M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |